SCHEMBL23584590

SCHEMBL23584590

CN(C)C[C@@H]1CC(F)(F)CCN1C[C@@H]1CC[C@H](c2ccc3c(N)ncnn23)O1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ DOT1L Q8TEK3 2/20 0.32
▸ PIK3CD O00329 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23584789 0.88 — —
SCHEMBL23584569 0.87 — —
SCHEMBL23584693 0.87 DOT1L (0.35) DOT1L
SCHEMBL23584473 0.83 DOT1L (0.33) DOT1L
SCHEMBL19344164 0.83 DOT1L (0.35) DOT1LPIK3CD
SCHEMBL23584486 0.81 DOT1L (0.33) DOT1L
SCHEMBL22434993 0.81 DOT1L (0.30) DOT1L
SCHEMBL22434994 0.80 — —
SCHEMBL23584694 0.80 CSNK2A2 (0.34) DOT1L
SCHEMBL19344174 0.79 POLRMT (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426664-B1 SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2021-06-30 — — EP disclosed
Send feedback